Quantcast
Last updated on April 19, 2014 at 17:21 EDT

Latest Vaccination Stories

2013-10-30 23:21:27

Vaccine Technology Market report categorizes the global vaccine market into technology class, types, end users, disease indication, and geography. http://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html (PRWEB) October 30, 2013 The "Vaccine Market - By Technology & Types, Trend Analysis By Various Classes – Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications – Infectious...

2013-10-29 12:28:04

Additional funding allocated to research nanoemulsion-adjuvanted HIV vaccine ANN ARBOR, Mich., Oct. 29, 2013 /PRNewswire/ -- NanoBio Corporation today announced that the company has been awarded an initial contract worth $5.5 million from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop a nanoemulsion (NE) adjuvant for use with a pandemic influenza vaccine. The total contract is valued at approximately...

2013-10-29 11:52:10

Scientists from the Center for Innovations in Medicine in the Biodesign Institute at Arizona State University have developed a comprehensive, microchip-based technology, called immunosignature diagnosis, which can rapidly and comprehensively measure an individual’s vaccine response, promising to take much of the initial guesswork out of predicting effective vaccines. Professor Stephen Albert Johnston and Joseph Barten Legutki, used a mouse model of influenza infection to determine how...

2013-10-28 08:28:31

November 1, 2013 at 2:00 PM EDT PRINCETON, N.J., Oct. 28, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that Christopher J. Schaber, PhD, President and Chief Executive Officer, Oreola Donini, PhD, Vice President of Preclinical Research and Development,...

Syria On High Alert, Possible Poliovirus Infections Detected In 22 People
2013-10-25 09:39:19

Lawrence LeBlond for redOrbit.com - Your Universe Online Last week the World Health Organization (WHO) reported a cluster of acute flaccid paralysis (AFP) cases in the Syrian Arab Republic. This cluster was first detected in early October in the Deir al-Zor province and is currently under investigation by public health officials. According to Reuters’ Stephanie Nebehay on Thursday (Oct. 24), the WHO reported that at least 22 people in Syria are suspected of having the wild poliovirus...

2013-10-24 23:03:56

The UN Foundation and the Liechtenstein Embassy to the US announce a three-year commitment of US$75,000 to support worldwide polio eradication efforts. Washington, DC (PRWEB) October 24, 2013 The United Nations Foundation applauds a generous, three-year commitment of US$75,000 from the government of the Principality of Liechtenstein to the Global Polio Eradication Initiative (GPEI). Championed by Liechtenstein’s Ambassador to the U.S. Claudia Fritsche, the gift will contribute to polio...

2013-10-24 08:33:48

FREDERICK, Md., Oct. 24, 2013 /PRNewswire/ -- Vaccinogen, Inc., (OTC.QB: VGEN) a cancer vaccine company, today announced that noted pediatric neurosurgeon Benjamin S. Carson, M.D. and prominent oncologist Jan B. Vermorken, M.D., Ph.D. have joined the company's medical advisory board. Drs. Carson and Vermorken complement Vaccinogen's existing medical advisory board members: John S. Macdonald, M.D., a highly recognized colorectal surgeon; Herbert C. Hoover, Jr., M.D., a leader in the...

2013-10-23 23:01:18

Society for Immunotherapy of Cancer Annual Meeting & Associated Programs - November 7-10, 2013 in National Harbor, MD Milwaukee, WI (PRWEB) October 23, 2013 Hear first-hand the latest cutting-edge cancer immunotherapy research straight from the experts at SITC 2013, November 7-10, 2013 at the Gaylord National Hotel and Convention Center in National Harbor, MD. Members of the media can register free of charge for a press pass, granting access to exciting educational programs that...

2013-10-22 12:29:12

Ashley Birkett, PhD, to lead key product development program at PATH WASHINGTON, Oct. 22, 2013 /PRNewswire-USNewswire/ -- PATH announced today the appointment of Ashley Birkett, PhD, as director of its Malaria Vaccine Initiative (MVI), which drives the development of safe and effective vaccines for the fight against malaria. The malaria parasite still kills an estimated 660,000 people each year, most of them children in sub-Saharan Africa, and half the world's population remains at...

2013-10-21 23:02:01

Representatives of 10 grantee programs participating in a two-year initiative, “Improving Understanding of Adolescent Vaccination through Innovative Local Public Health Demonstration Projects,” gathered at the Cincinnati Children’s Hospital Medical Center last week to discuss strategies and tactics for increasing adolescent immunization rates for a range of vaccines important for teens and young adults, including human papillomavirus, meningococcal, influenza, and Tdap (tetanus,...


Latest Vaccination Reference Libraries

0_ac8af9115d7f37daaaa2af4dba273fb1
2011-01-11 14:17:29

The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...

More Articles (1 articles) »